320 related articles for article (PubMed ID: 11896157)
1. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.
Garcia M; Vanhoutte P; Pages C; Besson MJ; Brouillet E; Caboche J
J Neurosci; 2002 Mar; 22(6):2174-84. PubMed ID: 11896157
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum.
Vis JC; Verbeek MM; de Waal RM; ten Donkelaar HJ; Kremer B
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):68-76. PubMed ID: 11299004
[TBL] [Abstract][Full Text] [Related]
3. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
[TBL] [Abstract][Full Text] [Related]
4. Expanded huntingtin activates the c-Jun terminal kinase/c-Jun pathway prior to aggregate formation in striatal neurons in culture.
Garcia M; Charvin D; Caboche J
Neuroscience; 2004; 127(4):859-70. PubMed ID: 15312898
[TBL] [Abstract][Full Text] [Related]
5. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.
Bizat N; Hermel JM; Boyer F; Jacquard C; Créminon C; Ouary S; Escartin C; Hantraye P; Kajewski S; Brouillet E
J Neurosci; 2003 Jun; 23(12):5020-30. PubMed ID: 12832525
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 Promotes Mitochondrial Dysfunction-Triggered Striatal Neurodegeneration via Autophagy and Apoptosis Activation.
Qi L; Sun X; Li FE; Zhu BS; Braun FK; Liu ZQ; Tang JL; Wu C; Xu F; Wang HH; Velasquez LA; Zhao K; Lei FR; Zhang JG; Shen YT; Zou JX; Meng HM; An GL; Yang L; Zhang XD
PLoS One; 2015; 10(11):e0142901. PubMed ID: 26565401
[TBL] [Abstract][Full Text] [Related]
7. The 3-NP Model of Striatal Neurodegeneration.
Brouillet E
Curr Protoc Neurosci; 2014 Apr; 67():9.48.1-9.48.14. PubMed ID: 24723322
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
[TBL] [Abstract][Full Text] [Related]
9. C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis.
Willaime-Morawek S; Brami-Cherrier K; Mariani J; Caboche J; Brugg B
Neuroscience; 2003; 119(2):387-97. PubMed ID: 12770554
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of bcl-2 and bcl-x mRNA coincides with apoptosis following intracerebral administration of 3-nitropropionic acid.
Sato S; Gobbel GT; Honkaniemi J; Li Y; Kondo T; Murakami K; Sato M; Copin JC; Sharp FR; Chan PH
Brain Res; 1998 Oct; 808(1):56-64. PubMed ID: 9795133
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid.
Akashiba H; Ikegaya Y; Nishiyama N; Matsuki N
J Biol Chem; 2008 Mar; 283(10):6594-606. PubMed ID: 18182390
[TBL] [Abstract][Full Text] [Related]
13. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
Vis JC; Verbeek MM; De Waal RM; Ten Donkelaar HJ; Kremer HP
Neuropathol Appl Neurobiol; 1999 Dec; 25(6):513-21. PubMed ID: 10632901
[TBL] [Abstract][Full Text] [Related]
14. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury.
Herdegen T; Claret FX; Kallunki T; Martin-Villalba A; Winter C; Hunter T; Karin M
J Neurosci; 1998 Jul; 18(14):5124-35. PubMed ID: 9651196
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3.
Schroeter H; Spencer JP; Rice-Evans C; Williams RJ
Biochem J; 2001 Sep; 358(Pt 3):547-57. PubMed ID: 11535118
[TBL] [Abstract][Full Text] [Related]
16. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
Suganya SN; Sumathi T
Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694
[TBL] [Abstract][Full Text] [Related]
17. Modulation of apoptotic regulatory proteins and early activation of cytochrome C following systemic 3-nitropropionic acid administration.
Antonawich FJ; Fiore-Marasa SM; Parker CP
Brain Res Bull; 2002 Mar; 57(5):647-9. PubMed ID: 11927368
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
Shear DA; Dong J; Gundy CD; Haik-Creguer KL; Dunbar GL
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1217-40. PubMed ID: 9829299
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity by Activating the Keap1-Nrf2-ARE Pathway and Inhibiting the MAPKs and NF-κB Pathways.
Jang M; Cho IH
Mol Neurobiol; 2016 May; 53(4):2619-35. PubMed ID: 26096705
[TBL] [Abstract][Full Text] [Related]
20. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
